Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors

Gelijkaardige items

• COX-2 selective inhibitors - they are still the best treatment for many patients!
  door: K Brune
  Gepubliceerd in: (2005-03-01)
• The Effect of Selectivity of Inhibitors to Cox-2 Enzyme on Hepatobiliary and Platelet Function in Patients with Osteoarthritis
  door: Ali M. Hadi, et al.
  Gepubliceerd in: (2010-01-01)
• Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma
  door: M Tinguely, et al.
  Gepubliceerd in: (2006-07-01)
• The COX-2 inhibitors: a reasoned review of the data
  door: L Simon
  Gepubliceerd in: (2005-07-01)
• Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion
  door: T Kistler, et al.
  Gepubliceerd in: (2001-04-01)